Granulocyte-colony stimulating factor and retinoic acid cooperatively induce granulocyte differentiation of acute promyelocytic leukemia cells in vitro. 1989

T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
Department of Hematology, Showa University School of Medicine, Tokyo.

The interaction of granulocyte-colony stimulating factor (G-CSF) and retinoic acid (RA) in proliferation and differentiation of acute promyelocytic leukemia (APL) cells was examined. G-CSF stimulated proliferation of APL cells at concentrations of 0.1 to 50 ng/ml in a dose dependent manner. More than 10(-8) M RA induced granulocytic differentiation of APL cells. Although G-CSF induced lysozyme activities in APL cells, it alone did not induce terminal differentiation of APL cells. G-CSF significantly enhanced the RA-induced granulocytic differentiation of APL cells in vitro. Enhancement by G-CSF was not due to the prolongation of survival of RA-induced differentiated cells, but the differentiation-inducing effects of G-CSF might be evident only in the presence of RA. Since G-CSF has a potential to induce the granulocytic differentiation of myeloid leukemia cells, G-CSF in combination with RA may be applicable in differentiation induction therapy for some types of myeloid leukemia.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003115 Colony-Stimulating Factors Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF). MGI-1,Macrophage-Granulocyte Inducer,Colony Stimulating Factor,Colony-Stimulating Factor,MGI-1 Protein,Myeloid Cell-Growth Inducer,Protein Inducer MGI,Cell-Growth Inducer, Myeloid,Colony Stimulating Factors,Inducer, Macrophage-Granulocyte,Inducer, Myeloid Cell-Growth,MGI 1 Protein,MGI, Protein Inducer,Macrophage Granulocyte Inducer,Myeloid Cell Growth Inducer
D005260 Female Females
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
April 1994, Blood,
T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
May 2004, Leukemia research,
T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
January 2015, Cancer cell international,
T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
June 1995, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
August 1991, Zhonghua yi xue za zhi,
T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
August 1993, Internal medicine (Tokyo, Japan),
T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
May 1998, American journal of hematology,
T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
October 1996, International journal of hematology,
T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
July 1999, Blood,
T Nakamaki, and A Sakashita, and M Sano, and K Hino, and K Suzuki, and S Tomoyasu, and N Tsuruoka, and Y Honma, and M Hozumi
July 1988, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!